Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
Australian Indigenous HealthBulletin
 
  • Home
    • » Key resources and services
      • » Programs and projects
        • » Implications of nonencapsulated Streptococcus pneumoniae carriage for maintenance of antibiotic resistance genes and the efficacy of pneumococcal conjugate vaccine (Prenevar) for pneumococcal disease. (SPINICA)

Implications of nonencapsulated Streptococcus pneumoniae carriage for maintenance of antibiotic resistance genes and the efficacy of pneumococcal conjugate vaccine (Prenevar) for pneumococcal disease. (SPINICA)

 

Overview

This project aimed to monitor the prevalence of pneumococci bacteria not covered by the Prevenar vaccine. The Prevenar vaccine is currently administered to Indigenous Australian children and protects from disease caused by 7 types of pneumococcus, but studies showed that the remaining types of pneumococcus not included in the vaccine may become more prevalent.

In particular, the project examined the non-encapsulated pneumococcus which is an important replacement type in Indigenous children who have been vaccinated with Prevenar. Previously little was understood about the epidemiology of the is type of pneumococcus. This study assisted in the understanding of its relationship to other pneumococci, and its potential role as a reservoir of antibiotic resistance for pneumococci.

Abstract adapted from Menzies School of Health Research

Contacts

Menzies School of Health Research
John Matthews Building
Royal Darwin Hospital Campus
PO Box 41096
Casuarina NT 0811
Ph: (08) 8922 8196
Fax: (08) 8927 5187
Email: info@menzies.edu.au

Links

 
Last updated: 29 October 2013
 
Return to top